MedPath

Visual Function Abnormalities in Strabismus and Amblyopia and Response to Therapy

Recruiting
Conditions
Amblyopia
Strabismus
Interventions
Behavioral: Patching therapy, Glasses
Registration Number
NCT04310241
Lead Sponsor
The Cleveland Clinic
Brief Summary

Amblyopia and strabismus are characterized by a reduction in visual acuity, contrast sensitivity, grating acuity, vernier acuity, reading difficulties and binocular visual function deficits. Treated patients have residual visual function deficits. The purpose of the current study is to quantify various visual functions in amblyopic and strabismic participants at baseline, during and at the completion of treatment.

Detailed Description

To examine the response of therapy on visual functions in amblyopic and strabismic participants.

The following visual functions will be measured prior to treatment. Eye movements, contrast sensitivity, grating acuity, visual acuity, vernier acuity, binocular visual functions, reading and visual scanning will be measured. The testing will comprise of one or more of the above paradigms depending on participant's cooperation and understanding as majority of the study participants will be children. The above measurements will be repeated during amblyopia therapy ( which comprises of glasses, patching and/or atropine eye drops) and at the completion of treatment. For participants with strabismus requiring strabismus surgery the measurements will be repeated after strabismus surgery.

Recruitment & Eligibility

Status
RECRUITING
Sex
All
Target Recruitment
150
Inclusion Criteria
  • History of amblyopia or presence of amblyogenic risk factors.
Exclusion Criteria
  • History of neurologic disorders

Study & Design

Study Type
OBSERVATIONAL
Study Design
Not specified
Arm && Interventions
GroupInterventionDescription
AmblyopiaPatching therapy, GlassesClinical diagnosis of amblyopia
Primary Outcome Measures
NameTimeMethod
Visual functions0-3 years depending on duration of treatment

reading- reading speeds, eye movement measurements

Visual Functions0-3 years depending on duration of treatment

visual acuity

Secondary Outcome Measures
NameTimeMethod

Trial Locations

Locations (1)

Cleveland Clinic

🇺🇸

Cleveland, Ohio, United States

© Copyright 2025. All Rights Reserved by MedPath